GlassScriptPhysician profile
Kristofer Feeko
NPI 1326350679
$2,382.56
in general payments reported to CMS, 2019-2025
18 companies · $417 in 2025
The $417 reported for 2025 was more than what 75% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.93 · 2020: $39.60 · 2021: $257 · 2022: $485 · 2023: $462 · 2024: $635 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $535.98 | 2021-2024 | Senza |
| Abbott Laboratories | $405.36 | 2023-2025 | Eterna, Octrode, Proclaim |
| Boston Scientific Corporation | $318.34 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $177.64 | 2021-2023 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $145.79 | 2023-2025 | Belbuca |
| Medtronic, INC. | $139.21 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Averitas Pharma INC. | $131.92 | 2024-2025 | Qutenza |
| Vertos Medical, INC. | $119.19 | 2022 | |
| Merz North America, INC. | $87.93 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $73.56 | 2023-2025 | Dysport |
| Abbvie INC. | $54.53 | 2022-2023 | |
| Medtronic USA, INC. | $39.60 | 2020 | |
| Genzyme Corporation | $34.25 | 2023 | |
| Nalu Medical, INC. | $30.42 | 2025 | Nalu Neurostimulation System |
| Avanos Medical | $28.87 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.86 | 2025 | Ofev |
| Stimwave Technologies Incorporated | $17.87 | 2021 | |
| Tersera Therapeutics LLC | $14.24 | 2023 | Prialt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristofer Feeko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.